Clinical Study

Clinical Feature of Men Who Benefit from Dose Escalation of Naftopidil for Lower Urinary Tract Symptoms: A Prospective Study

Figure 2

The rate of change in the QOL score (ΔQOL) and each domain of the IPSS (Δ each domain) with 50 mg/day of naftopidil during the first 4 weeks.
804583.fig.002